PDF Print E-mail


Duke University School of Law
8th Annual Hot Topics in Intellectual Property
February 6, 2009

The 'Hot Topics' Symposium will be held on Friday, February 6, 2009 at Duke Law School. This year the panels will again focus on cutting-edge issues in intellectual property law

We are greatly honored to welcome Mr. Carl Horton, Chief IP Counsel to The General Electric Company as our keynote speaker. In his career at GE, Mr. Horton has handled a broad spectrum of IP matters involving a remarkably diversity of technologies in a number of different countries. Today his company is a leading global participant in a wide array of “green” technologies, including wind turbines, photovoltaics, hybrid vehicles and advance battery technologies, and is improving the “greenness” of more traditional technologies as well.

Our morning session will focus on the effect intellectual property protection has on the adoption of “clean” technologies, including in developing economies where the rapid expansion of industrial infrastructure has produced global environment effects. For technologies ranging from giant wind turbines to biofuel-producing micro-organisms and pollution-remediating nanotechnology, and players ranging from nations and established multi-national corporations to startups seeking their first round of venture capital, what effect is intellectual property protection having both on the global stage and in day-to-day practice ? The panel will be moderated by Professor Jerome Reichman, Bunyan S. Womble Professor of Law at Duke University School of Law.

Our afternoon panel will explore the problems and possibilities in crafting a legal regime to expedite bringing follow-on protein product pharmaceuticals (sometimes called “generic biologics”) to the market. While these products promise therapies and cures beyond anything achieved by the more common “small molecule” pharmaceuticals, the extra complexities involved in producing them has cast doubt on whether an abbreviated approval process for “generic” versions of these pharmaceuticals is practical, and whether it would produce the savings that resulted from the Hatch-Waxman Act. Our panel explores the issues from economic, legislative, and practitioner’s perspectives. The panel will be moderated by Professor Arti Rai, Elvin R. Latty Professor of Law at Duke University School of Law.

For more information, please contact This e-mail address is being protected from spambots, you need JavaScript enabled to view it .

Duke Law 8th Annual Hot Topics in Intellectual Property, February 6, 2009

Schedule of Activities

8:15 AM

Registration and Breakfast

8:45 AM

 

 

 Keynote

8:45 AM: Introduction

8:55 AM: Opening Remarks

9:00 AM:  Keynote Address; Mr. Carl Horton, Chief IP Counsel, The General Electric Co., Current Challenges Facing IP Practitioners

10:00 AM

Break

10:15 AM

 

 

Panel:  Clean Tech IP: Global Boon or Bane?
           
moderator: Prof. Jerome Reichman, Duke Law School

10:15 AM: Introduction

10:25 AM: Dr. Bertin Martens,  Do Intellectual Property Rights Affect the Transfer of Climate Change Technology to Developing Countries?

10:40 AM: Prof. Keith Maskus,  Economic Perspectives on Encouraging Transfer of Green Technologies: Problems and Prospects

10:55 AM: Dr. Douglas Pearson, Intellectual Property Rights in Clean Tech, a Patent Practitioner's Perspective

11:10 AM: Eric Lane, Keeping the LEDs on and the Electric Motors Running:  Clean Tech in Court After eBay

11:25 AM: Moderated Panel  Discussion and Question & Answer session

12:30 PM

 Catered Buffet Lunch

Donald Min discusses how in re Bilski affects apparatus and non-method claims

2:00 PM

  

Panel:  Generic Biologics: Possible ? Desirable? How?
           
moderator: Prof. Arti Rai, Duke Law School

2:00 PM: Introduction

2:10 PM: Prof. David Ridley,  The Market for Follow-On Biologics

2:25 PM: Madison Jellins,  Stumbling Blocks to Establishing a Regulatory Regime for Approval of Follow-On Biologics: Current Issues

2:40 PM: Dr. Mike Hostetler, Venture Capitalists, Start-ups, and Biogenerics: Current Activities and IP Strategy Impacts

2:55 PM: Ann Witt, Balancing Intellectual Property Concerns with Access to Affordable Medicines

3:10 PM

Break

3:25 PM

Moderated Panel Discussion and Question & Answer session

4:30 PM

Evening Reception